Abstract:To construct a recombinant attenuated Salmonella typhimurium oral live vector strain expressing the antigen of PRRSV GP5,the deleting N-terminal signal peptide sequence of PRRSV ORF5 gene was cloned and inserted into expression vector pYA3341.The recombinant plasmid pYA3341-ORF5 was electro-transformed into delta cya,delta crp,delta asd attenuated S.typhimurium vaccine strains X4550 to construct the live vaccine strains X4550(pYA3341-ORF5).The recombinant strain of X4550(pYA3341-ORF5) was identified,and its immunogenicity of expression protein,settlement and safety were evaluated.The recombinant strain of X4550(pYA3341-ORF5) immunity was evaluated by detecting antibody in immunized mouse model.Flow cytometry were performed to analyze the effect of recombinant strain to CD4+ and CD8+ T lymphocyte subsets of mice.Lymphocyte proliferative responses were tested.At last,the recombinant strain of X4550(pYA3341-ORF5) immunity was evaluated in swine model to detect antibody.The results showed that the recombinant plasmid has been constructed successfully.SDS-PAGE and Western blot could detect the GP5 protein band in S.typhimurium X4550(pYA3341-ORF5) and expressed GP5 protein could be recognized by the positive serum of PRRSV.The recombinant strain X4550(pYA3341-ORF5) could colonize and persist stably in mesenteric lymphnodes and spleens of mice.Its safety and reliability were verified by mouse experiment.The recombinant strains were inoculated to mice and swine by oral way and the serum GP5 antibody could be detected by ELISA and neutralization test.Through statistical analysis,the recombinant strain could increase CD4+ and CD4+/CD8+,but decreased CD8+ compared with the control group.This indicates that the recombinant strain has regulatory role for the cellular immune function.Lymphocyte proliferative responses results indicated that recombinant strain also induced an obvious cellular immune response.A recombinant oral live vaccine S.typhimurium strain X4550(pYA3341-ORF5) expressing PRRSV GP5 protein was constructed successfully.This live vaccine could be a basis to oral live vector vaccine for PRRSV infection.

Construction of the recombinant attenuated Salmonella typhimurium live vector vaccine strain expressing IBDV VP2 protein and its immunogenicity analysis

Construction of Cell Line Stably Expressing IBDV VP2 Protein Mutants

[Expression of the Infectious Bursal Disease Virus Polyprotein in Vero Cells Using Attenuated Salmonella Typhimurium As Transgenic Carrier].

Construction of an eukaryotic expression vector containing IBDV VP2/4/3 and ChIL-2 fusion gene and their expression in Vero cells

The Immunogenicity of CO-expressing Plasmid and Fusion Genes Plasmid Containing IBDV VP2/4/3 and ChIL-18 Genes

Construction and immunogenicity of the recombinant attenuated Salmonella typhimuriumlive vector vaccine strain expressing CSFV E2 antigen

Oral DNA vaccination with the polyprotein gene of infectious bursal disease virus (IBDV) delivered by attenuated Salmonella elicits protective immune responses in chickens

Construction of Recombinant Adenovirus Co-expressing VP1-2A of Foot and Mouth Disease Virus and Porcine IL-2 and Its Immune Effects

Construction of the Attenuated Salmonella Typhimurium Vaccine Strains Expressing PRRSV GP5 Antigen and Animal Immunity Test

Construction and Identification of a Recombinant Attenuated Salmonella Expressing Streptococcus suis sly Gene

Construction and Immunogenicity of an Attenuated Salmonella Harbouring IBV DNA Vaccines

Construction of the Attenuated Salmonella Typhimurium Vaccine Strains Expressing PRRSV GP3 Antigen

Immunogenicity and protective efficacy of orally administered recombinant Lactobacillus plantarum expressing VP2 protein against IBDV in chicken

Preparation of ChIL-2 and IBDV VP2 Fusion Protein by Baculovirus Expression System

Construction of the Recombinant Attenuated Salmonella typhimurium Live Vector Vaccine Strain Expressing JEV E Antigen and its Immunogenicity Analysis

Construction and Immunoprotective Effect of Recombinant Lactobacilli Expressing VP2 Protein of Infectious Bursal Disease Virus.

Recombinant Vp2 Protein of Infectious Bursal Disease Virus AH1 Strain Expressed in Insect Cells: a Vaccine Candidate

Safety,Stability and Lmmunogenicity of DNA Vaccine with Attenuated Salmonella Typhimurium As the Oral Delivery Vector

Construction and immunological evaluation of rGtHLJVP2 expressing VP2 protein of prevalent infectious bursal disease virus strain HLJ0504

[Construction, Safety and Immunogenicity Analysis of Attenuated Salmonella Typhimurium Harbouring TGEV DNA Vaccine].

Cloning and Sequence Analysis of the VP2 Gene in HZ Strain of Very Virulent Infectious Burial Disease Virus and Construction of Its Expression Plasmid